Literature DB >> 338308

Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.

G Planz, H W Gierlichs, A Hawlina, R Planz, W Stephany, K H Rahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 338308     DOI： 10.1007/bf00607422

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS.

Authors:  R P BUHS; J L BECK; O C SPETH; J L SMITH; N R TRENNER; P J CANNON; J H LARAGH
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  REDUCTION OF THE CENTRAL EFFECTS OF TRYPTOPHAN BY A DECARBOXYLASE INHIBITOR.

Authors:  J V HODGE; J A OATES; A SJOERDSMA
Journal:  Clin Pharmacol Ther       Date:  1964 Mar-Apr       Impact factor: 6.875

3.  A new inhibitor of decarboxylase of aromatic amino acids.

Authors:  W P BURKARD; K F GEY; A PLETSCHER
Journal:  Experientia       Date:  1962-09-15

4.  STUDIES ON THE METABOLISM AND MECHANISM OF ACTION OF METHYLDOPA.

Authors:  A SJOERDSMA; A VENDSALU; K ENGELMAN
Journal:  Circulation       Date:  1963-10       Impact factor: 29.690

5.  Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.

Authors:  G Bartholini; A Pletscher
Journal:  J Pharm Pharmacol       Date:  1969-05       Impact factor: 3.765

6.  Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

7.  Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.

Authors:  I Kuruma; G Bartholini; R Tissot; A Fletscher
Journal:  J Pharm Pharmacol       Date:  1972-04       Impact factor: 3.765

8.  Drug-induced changes of extracerebral dopa metabolism in man.

Authors:  R Tissot; G Bartholini; A Pletscher
Journal:  Arch Neurol       Date:  1969-02

9.  Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.

Authors:  M Henning
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1969

10.  The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.

Authors:  W Y Au; L G Dring; D G Grahame-Smith; P Isaac; R T Williams
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.